Figure 8
From: Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent
(a) UPLC-ESI-MS/MS chromatogram of Marizev® tablet extract containing 2 µg/mL of omarigliptin at 1.1 min. (b) HPLC-UV chromatogram of 10 µg/mL omarigliptin in bulk at 2.1 min.
